708 related articles for article (PubMed ID: 19494273)
1. Small interfering RNA against transcription factor STAT6 inhibits allergic airway inflammation and hyperreactivity in mice.
Darcan-Nicolaisen Y; Meinicke H; Fels G; Hegend O; Haberland A; Kühl A; Loddenkemper C; Witzenrath M; Kube S; Henke W; Hamelmann E
J Immunol; 2009 Jun; 182(12):7501-8. PubMed ID: 19494273
[TBL] [Abstract][Full Text] [Related]
2. Role of STAT6 and SMAD2 in a model of chronic allergen exposure: a mouse strain comparison study.
Hirota JA; Ask K; Fritz D; Ellis R; Wattie J; Richards CD; Labiris R; Kolb M; Inman MD
Clin Exp Allergy; 2009 Jan; 39(1):147-58. PubMed ID: 19032363
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen.
Park JW; Taube C; Yang ES; Joetham A; Balhorn A; Takeda K; Miyahara N; Dakhama A; Donaldson DD; Gelfand EW
J Allergy Clin Immunol; 2003 Dec; 112(6):1078-87. PubMed ID: 14657862
[TBL] [Abstract][Full Text] [Related]
4. Small interfering RNA against interleukin-5 decreases airway eosinophilia and hyper-responsiveness.
Huang HY; Lee CC; Chiang BL
Gene Ther; 2008 May; 15(9):660-7. PubMed ID: 18305576
[TBL] [Abstract][Full Text] [Related]
5. Loss of classical transient receptor potential 6 channel reduces allergic airway response.
Sel S; Rost BR; Yildirim AO; Sel B; Kalwa H; Fehrenbach H; Renz H; Gudermann T; Dietrich A
Clin Exp Allergy; 2008 Sep; 38(9):1548-58. PubMed ID: 18631347
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms preventing allergen-induced airways hyperreactivity: role of tolerance and immune deviation.
Tsitoura DC; Blumenthal RL; Berry G; Dekruyff RH; Umetsu DT
J Allergy Clin Immunol; 2000 Aug; 106(2):239-46. PubMed ID: 10932065
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic target validation of protein kinase C(PKC)-zeta for asthma using a mouse model.
Do JS; Park KS; Seo HJ; Kim JH; Hwang JK; Song EJ; Nam SY
Int J Mol Med; 2009 Apr; 23(4):561-6. PubMed ID: 19288034
[TBL] [Abstract][Full Text] [Related]
8. Respiratory syncytial virus infection does not increase allergen-induced type 2 cytokine production, yet increases airway hyperresponsiveness in mice.
Peebles RS; Sheller JR; Collins RD; Jarzecka AK; Mitchell DB; Parker RA; Graham BS
J Med Virol; 2001 Feb; 63(2):178-88. PubMed ID: 11170055
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of airway inflammation, hyperresponsiveness and remodeling by soy isoflavone in a murine model of allergic asthma.
Bao ZS; Hong L; Guan Y; Dong XW; Zheng HS; Tan GL; Xie QM
Int Immunopharmacol; 2011 Aug; 11(8):899-906. PubMed ID: 21354484
[TBL] [Abstract][Full Text] [Related]
10. Allergic sensitization is enhanced in early life through toll-like receptor 7 activation.
Phipps S; Hansbro N; Lam CE; Foo SY; Matthaei KI; Foster PS
Clin Exp Allergy; 2009 Dec; 39(12):1920-8. PubMed ID: 19735273
[TBL] [Abstract][Full Text] [Related]
11. Effect of anti-mIL-9 antibody on the development of pulmonary inflammation and airway hyperresponsiveness in allergic mice.
Kung TT; Luo B; Crawley Y; Garlisi CG; Devito K; Minnicozzi M; Egan RW; Kreutner W; Chapman RW
Am J Respir Cell Mol Biol; 2001 Nov; 25(5):600-5. PubMed ID: 11713102
[TBL] [Abstract][Full Text] [Related]
12. Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma.
Kim SH; Hong JH; Lee YC
Eur J Pharmacol; 2013 Feb; 701(1-3):131-43. PubMed ID: 23201068
[TBL] [Abstract][Full Text] [Related]
13. The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyperresponsiveness is overcome by interleukin-5.
Tomkinson A; Kanehiro A; Rabinovitch N; Joetham A; Cieslewicz G; Gelfand EW
Am J Respir Crit Care Med; 1999 Oct; 160(4):1283-91. PubMed ID: 10508820
[TBL] [Abstract][Full Text] [Related]
14. Oral administration of desloratadine prior to sensitization prevents allergen-induced airway inflammation and hyper-reactivity in mice.
Blümchen K; Gerhold K; Thorade I; Seib C; Wahn U; Hamelmann E
Clin Exp Allergy; 2004 Jul; 34(7):1124-30. PubMed ID: 15248861
[TBL] [Abstract][Full Text] [Related]
15. Comparison of acute inflammatory and chronic structural asthma-like responses between C57BL/6 and BALB/c mice.
Van Hove CL; Maes T; Cataldo DD; Guéders MM; Palmans E; Joos GF; Tournoy KG
Int Arch Allergy Immunol; 2009; 149(3):195-207. PubMed ID: 19218812
[TBL] [Abstract][Full Text] [Related]
16. siRNA as a therapy for asthma.
Huang HY; Chiang BL
Curr Opin Mol Ther; 2009 Dec; 11(6):652-63. PubMed ID: 20072942
[TBL] [Abstract][Full Text] [Related]
17. A mouse model of airway disease: oncostatin M-induced pulmonary eosinophilia, goblet cell hyperplasia, and airway hyperresponsiveness are STAT6 dependent, and interstitial pulmonary fibrosis is STAT6 independent.
Fritz DK; Kerr C; Fattouh R; Llop-Guevara A; Khan WI; Jordana M; Richards CD
J Immunol; 2011 Jan; 186(2):1107-18. PubMed ID: 21160052
[TBL] [Abstract][Full Text] [Related]
18. Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma.
Blease K; Schuh JM; Jakubzick C; Lukacs NW; Kunkel SL; Joshi BH; Puri RK; Kaplan MH; Hogaboam CM
Am J Pathol; 2002 Feb; 160(2):481-90. PubMed ID: 11839568
[TBL] [Abstract][Full Text] [Related]
19. Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity.
Yang M; Hogan SP; Mahalingam S; Pope SM; Zimmermann N; Fulkerson P; Dent LA; Young IG; Matthaei KI; Rothenberg ME; Foster PS
J Allergy Clin Immunol; 2003 Nov; 112(5):935-43. PubMed ID: 14610483
[TBL] [Abstract][Full Text] [Related]
20. NF-kappa B/Rel transcription factors: c-Rel promotes airway hyperresponsiveness and allergic pulmonary inflammation.
Donovan CE; Mark DA; He HZ; Liou HC; Kobzik L; Wang Y; De Sanctis GT; Perkins DL; Finn PW
J Immunol; 1999 Dec; 163(12):6827-33. PubMed ID: 10586083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
